BLOG

biospace

Get to Know Jonathan Rigby, Group CEO of Revolo Biotherapeutics

BioSpace recently spoke with Jonathan Rigby, Group CEO of Revolo Biotherapeutics, a biotherapeutic company working to revolutionize the treatment of autoimmune and allergic diseases by achieving superior long-term disease remission through resetting the immune system.